Aleglitazar

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Aleglitazar
Aleglitazar.svg
Identifiers
CAS number 475479-34-6 N
PubChem 10274777
ChemSpider 8450255 YesY
DrugBank DB08483
KEGG D08845 YesY
ChEMBL CHEMBL519504 YesY
Jmol-3D images Image 1
Image 2
Properties
Molecular formula C24H23NO5S
Molar mass 437.51 g mol−1
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
 N (verify) (what is: YesY/N?)
Infobox references

Aleglitazar is a peroxisome proliferator-activated receptor agonist (hence a PPAR modulator ) with affinity to PPARα and PPARγ, which was under development by Hoffmann–La Roche for the treatment of type II diabetes.[1] It is no longer in phase III clinical trials.[2]

References[edit]

  1. ^ "Statement on a nonproprietary name adopted by the USAN Council: Aleglitazar". United States Adopted Names. American Medical Association. Retrieved 2008-08-17. 
  2. ^ "Roche halts diabetes drug trial in blow to pipeline". Roche. Retrieved 2013-07-10.